- Stocks
- Consumer Defensive
- NASDAQ: CLXT

Price (delayed)

$5.39

Market cap

$26.81M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.49

Enterprise value

$39.1M

Calyxt, based in Roseville, Minnesota, is a technology company with a mission to deliver plant-based innovations for a better world. Founded in 2010, Calyxt uses its proprietary TALEN® gene editing

The gross profit has soared by 186% year-on-year and by 6% since the previous quarter

CLXT's EPS is up by 46% year-on-year and by 6% since the previous quarter

The company's revenue has shrunk by 99% YoY but it rose by 6% QoQ

The equity has dropped by 82% year-on-year and by 63% since the previous quarter

The quick ratio has plunged by 77% from the previous quarter and by 74% YoY

What are the main financial stats of CLXT

Market
Valuations
Earnings

Shares outstanding

4.97M

Market cap

$26.81M

Enterprise value

$39.1M

Price to earnings (P/E)

N/A

Price to book (P/B)

9.98

Price to sales (P/S)

159.46

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

234.11

Revenue

$167,000

EBIT

-$16.58M

EBITDA

-$14.93M

Free cash flow

-$16.31M

Per share
Balance sheet
Liquidity

EPS

-$3.49

Free cash flow per share

-$3.3

Book value per share

$0.54

Revenue per share

$0.03

TBVPS

$4.11

Total assets

$20.29M

Total liabilities

$17.62M

Debt

$14.34M

Equity

$2.67M

Working capital

-$1.63M

Debt to equity

5.38

Current ratio

0.61

Quick ratio

0.49

Net debt/EBITDA

-0.82

Margins
Efficiency
Dividend

EBITDA margin

-8,937.1%

Gross margin

100%

Net margin

-9,979.6%

Operating margin

-12,421.6%

Return on assets

-65.7%

Return on equity

-205.1%

Return on invested capital

-56.3%

Return on capital employed

-103.1%

Return on sales

-9,925.1%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Calyxt stock price performed over time

Intraday

10.91%

1 week

33.42%

1 month

87.15%

1 year

-84.77%

YTD

-63.46%

QTD

-84.15%

How have Calyxt's revenue and profit performed over time

Revenue

$167,000

Gross profit

$167,000

Operating income

-$20.74M

Net income

-$16.67M

Gross margin

100%

Net margin

-9,979.6%

The gross profit has soared by 186% year-on-year and by 6% since the previous quarter

The company's revenue has shrunk by 99% YoY but it rose by 6% QoQ

The net income has grown by 33% YoY

CLXT's operating income is up by 19% year-on-year and by 7% since the previous quarter

What is Calyxt's growth rate over time

What is Calyxt stock price valuation

P/E

N/A

P/B

9.98

P/S

159.46

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

234.11

CLXT's EPS is up by 46% year-on-year and by 6% since the previous quarter

The P/B is 127% above the 5-year quarterly average of 4.4

The equity has dropped by 82% year-on-year and by 63% since the previous quarter

The company's revenue has shrunk by 99% YoY but it rose by 6% QoQ

The stock's price to sales (P/S) is 49% less than its 5-year quarterly average of 314.5

How efficient is Calyxt business performance

The ROE has contracted by 38% YoY and by 36% from the previous quarter

The ROIC has grown by 17% year-on-year and by 4.1% since the previous quarter

The ROA has contracted by 16% from the previous quarter and by 8% YoY

CLXT's return on sales is up by 7% since the previous quarter

What is CLXT's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for CLXT.

How did Calyxt financials performed over time

The total assets is 15% more than the total liabilities

The quick ratio has plunged by 77% from the previous quarter and by 74% YoY

The current ratio has plunged by 76% from the previous quarter and by 69% YoY

CLXT's debt to equity has surged by 188% since the previous quarter

The equity has dropped by 82% year-on-year and by 63% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.